Arcturus Therapeutics Holdings Inc. is a messenger RNA medicines company focused on developing therapeutics and vaccines for infectious diseases and rare disorders. The company’s core platforms include STARR, a self-amplifying mRNA technology, and LUNAR, a lipid-mediated delivery system designed to help deliver RNA medicines into the body. Its current work centers on liver and respiratory rare diseases, with programs aimed at conditions such as cystic fibrosis and ornithine transcarbamylase deficiency, alongside vaccine candidates for seasonal and pandemic influenza and COVID-19. Arcturus Therapeutics also supports drug substance and drug product manufacturing capabilities as part of its RNA medicine development and commercialization activities. Headquartered in San Diego, California, Arcturus Therapeutics Holdings Inc. plays a specialized role in the biotechnology market by advancing RNA-based approaches for both therapeutic and preventive applications.
Website10285 Science Center Drive
San Diego, CA, 92121
United States
Arcturus Therapeutics (ARCT) shares rose 6.3% in Thursday afternoon trading, a day after it reported
Arcturus Therapeutics (ARCT) surged over 6% after sharing positive Phase 2 interim data for its OTC deficiency drug, ARCT-810.
Citi upgraded Arcturus to ‘Buy’ and raised the price target to $20 from $8, according to The Fly.
Investors talking about ARCT also mention
What share of all stock conversation is about ARCT?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% +0 | 0.01% +0 | 0% 0 | 0% -0.02 |
Of the messages about ARCT that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% 0 | 94.06% -5.94 | 98.35% +10.92 | 69.02% -19.25 | ||
| Bearish | 0% 0 | 5.94% new | 1.65% -10.92 | 30.98% +19.25 |
Of the messages about ARCT that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 83.76% | 12.17% | ||
| Technical Analysis | — | 0% | 9.4% | 10.42% | ||
| Analysts | — | 0% | 5.98% | 37.18% | ||
| Controversies | — | 0% | 0.85% | 0.25% | ||
| Macro | — | 0% | 0% | 36.29% | ||
| Earnings | — | 0% | 0% | 3.7% |
Of the messages about ARCT, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 38.98% | 37.65% | 24.19% | ||
| Newcomers | 0% | 61.02% | 62.35% | 75.81% |